You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III basal cell carcinoma of the lip

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Renal Cell Carcinoma Trial (Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 11, 2023

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +6 more
  • hypofractionated radiation therapy
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +4 more
  • Near Infrared Imaging
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 5, 2022

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Oct 10, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +20 more
  • Ipilimumab
  • +3 more
  • Tampa, Florida
  • +6 more
Jan 13, 2023

NSCLC Trial in Beijing

Recruiting
  • NSCLC
    • Beijing, China
      Yuyan Wang
    Oct 10, 2023

    NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Sugemalimab and Chemotherapy
    • Changsha, China
      Hunan Cancer Hospital
    Jul 7, 2023

    Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous

    Suspended
    • Advanced Head and Neck Squamous Cell Carcinoma
    • +17 more
    • Gilbert, Arizona
    • +19 more
    Dec 31, 2022

    Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +11 more
    • KEYTRUDA®
    • (no location specified)
    Nov 17, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

    Not yet recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +12 more
    • Biopsy
    • +8 more
    • (no location specified)
    Jun 8, 2023

    Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

    Recruiting
    • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +24 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    May 18, 2022

    Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)

    Available
    • Cutaneous Melanoma, Stage III
    • +3 more
    • IFx-Hu2.0
    • (no location specified)
    Aug 5, 2022

    Omitting Clinical Target Volume in Radical Treatment of

    Not yet recruiting
    • Immunotherapy
    • +3 more
    • IMRT+adjuvant immunotherapy
    • (no location specified)
    Jun 9, 2023

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

    Recruiting
    • Nonsmall Cell Lung Cancer
    • +3 more
    • Genomically Guided Radiation Therapy (RT)
    • Tampa, Florida
      Moffitt Cancer Center
    May 23, 2023

    Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

    Not yet recruiting
    • Stage III Non-small Cell Lung Cancer
    • (no location specified)
    Jun 3, 2023

    Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)

    Recruiting
    • Merkel Cell Carcinoma
    • +5 more
    • Port Macquarie, New South Wales, Australia
    • +17 more
    Aug 30, 2022

    Merkel Cell Carcinoma Trial in Wollstonecraft (Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination)

    Not yet recruiting
    • Merkel Cell Carcinoma
    • Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination
    • Wollstonecraft, New South Wales, Australia
      Melanoma Institute Australia
    Nov 21, 2023

    Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

    Not yet recruiting
    • Stage III NSCLC
    • Surgery
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Feb 21, 2023

    Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal

    Not yet recruiting
    • Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
    • +15 more
    • Best Practice
    • +9 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Aug 23, 2022